The deal expands the pharmaceutical company’s portfolio of cancer drugs. Source link
New drugs to defeat “superbug” bacteria aren’t reaching patients. Source link
Weight-loss drugs affect the brain in ways that help researchers understand how the body regulates weight. Source link
Novo Nordisk’s anti-obesity drug reduced people’s risk of suffering heart attacks, strokes and cardiovascular deaths by 20%. Source link
Costs are mounting for popular drugs such as Wegovy, a cousin of Ozempic, and healthcare plans are restricting coverage to…
Venture capitalist Luke Evnin has financed several successful biotechnology startups that develop treatments for cancer. Now he is encouraging drugmakers to tackle…
Drugmaker Mallinckrodt is talking to hedge funds about filing for bankruptcy and avoiding payments intended to help people addicted to…
The biotech cited the launch of Alzheimer’s drug Leqembi as part of its new focus on big-return products. Source link
China remains attractive to global pharmaceutical companies even as many multinationals shift their focus elsewhere. Source link
Net earnings at the pharmaceutical company rose 6.9% to $5.14 billion, or $1.96 a share. Source link